What happened in this episode?
Harvard evolutionary biologist Daniel Lieberman joins Chris Williamson to discuss what an evolutionary perspective can and cannot add to modern debates about dieting, and why he says many dietary movements become tribal. Lieberman argues that large-scale evidence tends to favour plant-heavy diets over meat-heavy ones, while cautioning that nutrition research is difficult to interpret because diets substitute for one another and lifestyle factors confound observational studies.
He cites specific studies and mechanisms to explain why Mediterranean-style eating has strong support, including the Spanish PREDIMED trial, which he says was stopped early due to marked benefits. He is sceptical of marketing claims around “optimal” diets and criticises Blue Zones longevity branding, citing work he attributes to Oxford demographer Saul Newman that questions age-record reliability.
On longevity interventions, Lieberman says calorie restriction extends lifespan in some lab species but claims the evidence does not yet translate cleanly to primates or humans, describing a macaque replication he says found no longevity advantage. He also addresses intermittent fasting as “metabolic switching” between growth and repair pathways.
Lieberman calls processed and ultra-processed foods the dominant driver of obesity, discusses how food engineering (fat-sugar-salt combinations and texture) promotes overeating, and notes that calorie labels can misrepresent absorbed energy. On treatment, he says GLP-1 drugs can be transformative but raises concerns about muscle loss, high discontinuation, and weight regain, arguing prevention still depends on fixing the food environment and improving nutrition education.
